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Michael S LauerAbstract
In the current issue of Population Health Metrics, two reports paint a bleak picture of American public health. Both
physical inactivity and obesity remain highly prevalent; yet, it is not clear that increased physical activity will reduce
the burden of obesity. There continue to be widespread disparities in life expectancy across United States counties.
These reports appear against a backdrop of debate regarding how we should allocate our scarce resources for
improving health: should we focus more on improving access to high-quality medical care, or should we instead
focus on more and better public health interventions? While optimal solutions remain obscure, a look at prior
successes suggests that ultimately they will come from the conduct and implementation of rigorous science, and in
particular event-driven trials.
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school. Recently he published in the New York Times a
provocative letter about an impending doctor shortage.
He suggested lowering bars for foreign-trained physicians
[1]. Tim Wycoff, an experienced family physician sug-
gested in reply that the United States focus more on
public health interventions, “reining in the food and agri-
culture industry,” while promoting healthier diets along
with increased physical activity [1]. Busko acknowledged
that poor diet and lifestyle habits do account for much of
our chronic disease burden, but “sadly I do not see this
situation improving anytime soon [1].”
Just a few days after the New York Times published
this dialogue, the “Look AHEAD” investigators pub-
lished the results of a long-awaited trial of the impact of
lifestyle interventions on cardiovascular outcomes in pa-
tients with diabetes [2]. The investigators randomized
over 5,000 patients to an education control or to an in-
tensive intervention of caloric restriction and increased
physical activity. In some respects, the intervention
worked: it led to greater weight loss and better physical
fitness. But ultimately, it failed: there was no reduction
in the rates of cardiovascular events or of total mortality.
So, maybe Busko was right to dismiss public health in-
terventions. It’s simply impossible to improve diet and toCorrespondence: lauerm@nhlbi.nih.gov
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reproduction in any medium, provided the orincrease physical activity. And even if we could, who’s to
say that that will lead to better health?
In one of the two current reports, Dwyer-Lindgren et al.
used BRFSS data to describe 10-year changes in the preva-
lence of obesity and insufficient physical activity across
United States counties [3]. The authors found wide varia-
tions in both obesity and levels of physical activity. There
was a weak correlation between changes in physical activ-
ity and obesity: for every 1% increase in physical activity,
obesity prevalence was only 0.11% lower. The authors
concluded that increasing physical activity alone might
have little impact on the national obesity epidemic.
One reason we worry is that obesity may have an adverse
impact on long-term improvements in life expectancy.
Thus it is noteworthy that alongside Dwyer-Lindgren et al’s
report, Wang et al. report using county-specific mortality
data to describe changes in life expectancy between 1985
and 2010 [4]. Life expectancy has increased in both men
and women with a lower gender gap; however, geographic
variations in life expectancy persist, and in fact are
worsening.
Taken together, these reports paint a bleak picture for
United States public health. Obesity and physical inactivity
remain highly prevalent, with gross geographic disparities.
Increasing physical activity may not lessen obesity. Life ex-
pectancy may be improving, but we still lag behind much
of the rest of the developed world, and we still suffer from
gross disparities. To paraphrase Karl Malden, “What we
will do?”is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Lauer Population Health Metrics 2013, 11:10 Page 2 of 3
http://www.pophealthmetrics.com/content/11/1/10It is interesting that Wang et al. frame their investiga-
tion in the context of an American paradox: we spend
more for health care than any other country, yet our
health outcomes are relatively poor [5]. Why? Is it, as
suggested by Busko[1], because we have too few doctors?
Or because of inadequate access to health care? Or be-
cause, as suggested by Wycoff [1], Dwyer-Lindgren et al.
[3], and the Look AHEAD investigators[2], public health
interventions appear to have limited impact?
We cannot simply dismiss public health as ineffective.
After all, some of the most powerful interventions we
have come from public health: think public sanitation
and vaccines. David Hemenway recently argued that
public health is chronically underfunded for a variety of
reasons [6]. The benefits of public health lie in the fu-
ture, while people are oriented in the present. The bene-
ficiaries and the benefactors in public health are often
unknown; it’s difficult to get people excited about “statis-
tical lives” as well as about scientists and public health
officials who work in the background. And some public
health interventions directly threaten the bottom line of
powerful interests.
One might suggest another reason why public health
interventions generate less excitement, at least among
clinically oriented people whose primary focus is on
clinical manifestations of disease rather than on surro-
gates like physical activity, body mass index, or blood
pressure. Much, if not most, of the impressive reduction
in cardiovascular death rates we’ve seen over the past
50 years stem from interventions that were identified
through careful scientific investigations, including rigor-
ous, large-scale randomized trials [7]. We identified the
adverse impacts of elevated blood pressure and choles-
terol levels through systematic epidemiological studies,
studies that took into account possible biases and con-
founders [8]. We followed those studies with pros-
pective randomized trials, which clearly demonstrated
benefits [7].
A clinical investigator might ask for similar scientific
rigor in the sphere of population health. Observational
studies, like those published in the current issue of
Population Health Metrics, should measure and account
for confounders like income, education, smoking rates,
pollution levels, health care spending, and public health
policies. And, when possible, a clinical investigator might
insist on performance of randomized trials before prom-
ulgation and implementation of new public health pol-
icies. We should have the humility to say that, right
now, we do not know what “the right level” of physical
activity is. Should we be recommending 150 minutes a
week when 10 minutes a day may be adequate [9]?
Should we be recommending lower calorie, low-fat diets
when other kinds of diets may actually be better for
preventing cardiovascular events [10]?Some argue that it’s not possible to conduct randomized
public health trials, trials that are analogous to those con-
ceived by clinicians. Yet we have seen a number of exam-
ples in which randomized trials or “quasi-experiments”
were successfully conducted within populations. Recently
completed randomized trials assessed the health impacts
of access to medical care[11], prescription drug coverage
[12], and better quality housing [13]. A quasi-experiment
suggested that mass screening for neuroblastoma did not
reduce cancer mortality [14]. Esther Duflo has conducted
numerous randomized trials testing the impact of eco-
nomic policies on population well-being [15].
In our current environment of integrated health care and
“big data,” it may be increasingly possible to conduct large-
scale experiments at relatively low cost. Rather than arguing
that randomized trials are not possible, we should instead
focus our energies on how to conduct many trials, espe-
cially event-driven trials that will ultimately inform policies
and practices that work. The National Institutes of Health
Common Fund Health Care Systems “Collaboratory” is
currently funding seven pragmatic trials that focus on a
wide range of high-prevalence conditions, including sui-
cide, back pain, hospital-acquired infections, hypertension,
renal failure, and colon cancer, all as part of an effort to gain
expertise in how to leverage large-scale information infra-
structures to answer critical questions of relevance to public
health quickly, robustly, and efficiently [16]. At the same
time, the newly formed Patient-Centered Outcomes Re-
search Institute (PCORI) is launching a major infrastruc-
ture effort that aims to create platforms upon which many
“patient-centered” effectiveness studies could be designed
and conducted in short order 17]. In an ideal world, diverse
stakeholder groups, including clinical and public health
practitioners and researchers, would come together, ex-
ploiting new opportunities afforded by big data, integrated
health care, and when appropriate, one of science’s most
powerful of tools, randomization [18].
We often hear that we cannot insist on doing trials to
test absolutely everything, and, if we had, we never
would have built sewer systems or implemented anti-
smoking policies. Sanitation and smoking, though, are
exceptions that prove the rule. In both cases, carefully
conducted observational studies found huge effect sizes.
In those rare cases where effect sizes are huge, random-
ized trials are not needed.
Alex Busko has launched his medical career on a posi-
tive note, asking provocative questions and inviting
rigorous dialogue [1]. As is clear from the results of the
Look AHEAD study [2] and the currently published re-
ports of Dwyer-Lindgren et al. [3] and Wang et al. [4],
we are a far way off from knowing what kinds of lifestyle
and public health interventions, if any, might improve
the poor health outcomes associated with the obesity
epidemic. Yet we can also take comfort that through the
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experimental science, it’s only a matter of time before
we get there.
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